Concepedia

Robin Apblett

RA

Statistics

Publications

1

Citations

349

H-Index

1

Active since

2003

Affiliations

Immune Modulatory Therapies (United States)(Current)

Robin Apblett is an author at Immune Modulatory Therapies (United States) specializing in oncology, fully human antibody development, and growth factor signaling.

Publications per year

2003–2003

1

Publications

1

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Douglas Burtrum, Zhenping Zhu, Dan Lu et al. · PubMed · 2003 · 349 citations

, , +15

1–1 of 1